Precision oncology promised to transform cancer care by matching patients to targeted therapies based on their tumor’s genetic makeup, and in many respects, it has delivered. Comprehensive genomic profiling (CGP) has driven much of this progress, enabling clinicians to sequence hundreds of cancer-related genes at once and identify mutations that can be paired with treatment. […]
Multiomics
How Long-Read Sequencing Is Powering the Next Era of Clinical Genomics
The recent webinar “Long-read Whole Genome Sequencing: Enhancing Diagnostic Power Across Clinical Applications”, hosted by Genetic Engineering & Biotechnology News (GEN), saw Shareef A. Nahas, PhD, Chief Scientific Officer at Sampled, and Katarzyna (Kasia) Ellsworth, PhD, Senior Director of Clinical Operations at Rady Children’s Institute for Genomic Medicine (RCIGM), sit down to discuss and present […]
How Technology Partners Are Pioneering the Future of Genomic Medicine
The 2025 State of Multiomics & NGS hosted by Genetic Engineering & Biotechnology News (GEN) featured some of the world’s most brilliant minds in the field of multiomics. Francis Collins, MD, PhD, ‘father’ of the Human Genome Project (HGP), was featured as the keynote speaker and shared his insights on the transition from the HGP […]
Unlocking the Potential of Multiomics in Research and Discovery with Sampled’s Global Integrated Analytical Biorepository
Biomedical research is becoming more multi-disciplined to understand and develop treatments for complex diseases. For this reason, the integration of multiple omics (multiomics) technologies has emerged as a powerful approach for unraveling the complexities of biological systems. Multiomics is described as the comprehensive analysis of various omics data types such as genomics, transcriptomics, proteomics, and […]
